Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Director/PDMR Shareholding

12 Oct 2021 07:20

RNS Number : 7748O
Anpario PLC
12 October 2021
 

Anpario plc("Anpario" or the "Company")

 

Director/PDMR Shareholding

 

Anpario announces that, on 11 October 2021, it has allotted a total of 50,000 new Ordinary Shares. The Ordinary Shares have been issued at a subscription price of 620 pence per Ordinary Share, being the closing price of an Ordinary Share on 8 October 2021, pursuant to The Anpario plc Employees' JSOP (the "Plan").

 

The Ordinary Shares have been issued into the respective joint beneficial ownership of (i) Marc Wilson, Group Finance Director, and (ii) the trustee of the Trust upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director concerned, the Company and the Trustee. The subscription price has been paid by the Trust out of funds advanced to it by the Company.

 

The terms of the JOAs provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participating Director receives an amount equal to any growth in the market value of the jointly owned Ordinary Shares above the initial market value of 620 pence per share, less a "carrying cost" (equivalent to simple interest at 4.5 per cent per annum on the initial market value) and the Trust receives the initial market value of the jointly owned shares plus the carrying cost. Jointly owned Ordinary Shares will become vested if the participant remains with the Company for a minimum period of 3 years.

 

Effect of the transactions

 

The beneficial interests held before and after the above transactions and remaining unchanged are:

 

Director

Ordinary shares

SAYE options

Marc Wilson

9,676

5,577

 

The jointly owned Ordinary Shares held by the Directors of the Company before and after the above transactions will be:

 

Director

Interests in jointly owned Ordinary Shares prior to the transactions:

New interests in jointly owned Ordinary Shares issued under JSOP

Interests in jointly owned Ordinary Shares following the transactions

Marc Wilson

20,000

50,000

70,000

 

An application has been made to the London Stock Exchange plc for the admission to trading on AIM of 50,000 Ordinary Shares in respect of these shares awarded under the JSOP. It is expected that admission of these new Ordinary Shares will become effective on 15 October 2021 ("Admission"). These new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue.

 

Following Admission, the Company's total issued share capital is 23,678,196 Ordinary Shares. The Company holds 440,388 Ordinary Shares in Treasury. Therefore, the total number of voting rights in the Company is 23,237,808. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Share plan limits

On 16 September 2016, Anpario announced limits on future awards made under its share plans. That limit is the total number of new shares over which future awards may be made, when added to the total number of shares issued and issuable under awards granted on 16 September 2016 and any awards which are outstanding as at that date shall not exceed 16.3% of the total of the number of shares in issue from time to time.

 

The JSOP award mentioned above substantially utilises the remaining headroom under this share plan limit. Anpario considers it necessary to have in place a competitive senior executive employment package, including equity awards and to ensure that existing managers and directors are properly incentivised. As such, a review is currently being undertaken to determine potential future changes to share plan limits and awards, once this process has concluded then further details will be announced as appropriate.

 

 

 

Enquiries:

Anpario plc

 

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

Karen Prior, Corporate Responsibility Director & Company Secretary

+44(0) 1909 537380

 

 

 

Peel Hunt LLP (NOMAD)

+44 (0)20 7418 8900

Adrian Trimmings

 

Andrew Clark

 

Will Bell

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZMMGVZRGMZG
Date   Source Headline
17th Mar 20217:00 amRNSFinal Results
15th Mar 20213:38 pmRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSDirectorate Change
4th Feb 20212:54 pmRNSBlock Listing Application
3rd Feb 20214:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:30 pmRNSTotal Voting Rights
26th Jan 20217:00 amRNSTrading Statement and Board update
25th Jan 20217:00 amRNSDirectorate Change
18th Jan 20217:00 amBUSBlock listing Interim Review
8th Jan 20217:00 amBUSDirectorate change
9th Dec 202010:55 amBUSTotal Voting Rights
5th Nov 20205:03 pmBUSDirector/PDMR Shareholding
3rd Nov 202010:06 amRNSTotal Voting Rights
16th Oct 20201:22 pmRNSLady Oregon Goes Aloft
9th Oct 20207:17 amRNSDirector/PDMR Shareholding
2nd Oct 202012:13 pmRNSTotal Voting Rights
24th Sep 20207:00 amRNSChange of auditor
18th Sep 20204:24 pmRNSDirector/PDMR Shareholding
9th Sep 20207:00 amBUSHalf-year Report
17th Jul 202010:55 amRNSBlock listing Interim Review
7th Jul 20201:43 pmRNSTotal Voting Rights
3rd Jul 20203:42 pmRNSHolding(s) in Company
3rd Jul 20202:42 pmRNSHolding(s) in Company
25th Jun 20202:13 pmRNSResult of the AGM
25th Jun 20207:00 amRNSAGM Statement
18th Jun 20205:06 pmRNSHolding(s) in Company
1st May 20205:43 pmBUSNotice of AGM
1st May 202010:16 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSCOVID-19 Update and Patent Application
7th Apr 20208:45 amRNSTotal Voting Rights
18th Mar 20207:00 amBUSFinal Results
13th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20207:00 amRNSCompletion of Buyback Programme
12th Mar 20207:00 amRNSTransaction in Own Shares
11th Mar 20207:00 amRNSTransaction in Own Shares
10th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSTransaction in Own Shares
2nd Mar 20207:00 amRNSTransaction in Own Shares
25th Feb 20207:00 amRNSTransaction in Own Shares
24th Feb 20207:00 amRNSTransaction in Own Shares
20th Feb 20203:11 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSTransaction in Own Shares
12th Feb 20207:00 amRNSTransaction in Own Shares
7th Feb 20203:31 pmRNSHolding(s) in Company
7th Feb 202011:16 amRNSHolding(s) in Company
7th Feb 20207:00 amRNSTransaction in Own Shares
5th Feb 20205:14 pmRNSShare Buyback Programme
5th Feb 20209:00 amRNSDirector/PDMR Shareholding
30th Jan 20203:51 pmRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.